StockDuty
Jun 18, 2026 06:38 PM ET
Catalyst
Earnings
$SRPT — SAREPTA THERAPEUTICS INC
SRPT
$16.85
+5.18%
What changed
$SRPT — SAREPTA THERAPEUTICS INC Q1: - Revenue: $731M - Adj EPS: $3.16 vs $1.05 🟢 - Adj operating margin: 49.0% (📈 +89.4pp YoY) Guidance: - FY revenue: $1.20B-$1.40B vs $1.84B est 🔴
Why it matters
Q1:
Sources
pipeline
Related signals
🚨 100% of S&P 500 market cap has now reported Q1 2026. →
📊 S&P 500 Q2 2026 Earnings Update — Mid-season →
$BBY — AVOID 📊 | 6 MONTHS THESIS →